{"ticker": {"uuid": "123478f6-0aa1-4761-94cd-3a4f9c13648f", "symbol": "4506", "name": "Sumitomo Pharma Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Sumitomo Pharma Shares Drop After Stem-Therapy Backing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOekExOVpFM1BwQ2ZFbDV4MVc3d3JxN2dwVHppQjNBbXhjUy1yeWlHaVk2UDdZVzc1MmtHS1BkVno0MXZuVDRxWmd4N0lrb3FZMG91NFJYU3FnXzE1VUFzUWhwcDZGV3NYSzJ0TFowbEotU3MtQ2hiZHJmcHBwT09Db2l1QXpENkY5ellXUEJkdmxGY0RLMmprZ2JORkw2b0RIRWI3Wi12MFU?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Pharma Q3 FY2025 slides: North American sales drive 408% profit surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPY3MzWGJSS2pFNDJpaDhGV0h0S21SbDhvSmRnbVJWaUdGZnRlcGxlUkFPZGdqWkkzVzFfZVZLSU9MSTlmM00xZFZqd2JkS0VmWDM1TzJ3ZldVMjhUWnp3TW0yYzNjRFFQRjBBT0pIYU9aRnFZcU5MT3I1WWcyYkRXbjNYb0o2OWdmMENONDhtTWdkTGJPY0lOR0c2M2t1T1pveW9vc0Rpc1BHYlZ0VDNqU29SLTh1bkdhLXNuenJyXzEyM0hqeWdvNVBncjNsdw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sumitomo Pharma (TSE:4506) Using Too Much Debt?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-02T08:00:00+00:00", "published_display": "02 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Pharma Forms New Entity for Asian Business Spinoff", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQWtORHo4SGRRSi1GemFVOUtHZG15ZWxOSXNRQVVOcHpDNkJaMzEycFVzcFZiWjZYU2N1S3dhdXRqV0ItRlA1eDFiQ29Rdy1tS1NhZFdkbnJxZ2FfX1VlUnM2SldGTEEtNDRDaENPcDlKVDIxdDJzYU4zU3ZoVUg3cDZLOHBvdkN6QUZPcEliemNnMHBfVGxndy1qdjJEMkJmZTFvRGtxLWJQN0hVcGIyNHNNbjZhZEZrQ3ppZ0R6YTVDN0pGcHhWbXY0ZUxsaUpHNldONnR0OGd3MGl6bzNBZGdB?oc=5", "source_name": "marketscreener.com", "published_at": "2025-05-29T07:00:00+00:00", "published_display": "29 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Establishment of a Pharmaceutical Strategic Platform\uff1a Succession of Sumitomo Pharma\u2019s Business in Asia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5JNGVTUGVTZVdJN2ZwRUMtUnlRSzBCT2hkaXdEbEM0THl1emNDWU80RmhHb0pHQzl3TEY3M0s5Mkc3X0JiUEJEajhOdGhYbi13N1g4eVdLSUsyM2x1cFFIbURHcy1rbjA?oc=5", "source_name": "marubeni.com", "published_at": "2025-04-01T07:00:00+00:00", "published_display": "01 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUW4ybXdmX2dtb0xSZ0tBeF8tZmhaMXlzZ081enduWm9lMFlzaC1pVlRLeExtaUtyVEhYNzdzbWVjVzhKTjJxczFUcXRXNE5FeWxWN1RtMWVOUTFZLUxjaC1jdDhvc2JXZk5OT0N0TkhoejhSQ09aZG8xMDFCZlF3eUgwXzV3NVRmVXQxNnFMM0lSTDg1djJjaHNSdTNBRl95NWl3d1dLc1hVMmllX1U0a1pkWGluYjJieU4zNkMzTnkzaWpQc1RHR1E4QTdwTndBS3ViTGpGTmpGQmh2TUE?oc=5", "source_name": "PR Newswire", "published_at": "2022-10-23T07:00:00+00:00", "published_display": "23 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Offers to Buy All of Myovant in Deal Worth $2.5 Billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPTjNzaGNrVnEzZUI4SUQxUmk5bEtseWdqWk9rNkFQZmU1Q0F1MER5bE9XMmdXUGEzdUkzcHlELXJEMTkzWUVZUHVqNnNVc1BKUmdPTzNzcF9VNW1hRFV1OTJMbmxTV0FxT0dHUVJiRW9hYm5neVQ4djU3dUx4ZURxbGVtM19qQjZXRVZpeVBHOFVUTVYwcVh6aE9LWXZYMkI2RExRb0RHMzVLcHRmLVhacWk5c3A?oc=5", "source_name": "Bloomberg.com", "published_at": "2022-10-03T07:00:00+00:00", "published_display": "03 Oct 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitovant Biopharma and Sumitomo Pharma Announce Offer to Acquire Outstanding Shares of Myovant Sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxNWEt4SnNOMnNWamsxWkNfOWNaRTJocFpSaTdBWGI5SzR6UzBiNW9NMkN6Vi1HczBOTDM5WkV6enZvTkk2LW1HaHItaVpJVG5reEpvS3d1YjFFa08yRXRsQlU3QUsyc0c3QUlBbURoYWpnWTQ0QjJ2UThRX0Z6TWRoNkVCeUh3QUdxQjhOZ1k1bmxEMWswNTZwUkJ3c1hWYWxMNjFiMnJnbzVoX05rQjdPblVrQjEya1VQQ0hQMzJxbXVncDFnMlphdXNWa2Z5cUpHS3pyaWZ6dVJHcC1PVGhxR25hRjB0QXloTFkxTDA5MDlwMUE?oc=5", "source_name": "PR Newswire", "published_at": "2022-10-02T07:00:00+00:00", "published_display": "02 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sumitomo Pharma Shares Drop After Stem-Therapy Backing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOekExOVpFM1BwQ2ZFbDV4MVc3d3JxN2dwVHppQjNBbXhjUy1yeWlHaVk2UDdZVzc1MmtHS1BkVno0MXZuVDRxWmd4N0lrb3FZMG91NFJYU3FnXzE1VUFzUWhwcDZGV3NYSzJ0TFowbEotU3MtQ2hiZHJmcHBwT09Db2l1QXpENkY5ellXUEJkdmxGY0RLMmprZ2JORkw2b0RIRWI3Wi12MFU?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Pharma Q3 FY2025 slides: North American sales drive 408% profit surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPY3MzWGJSS2pFNDJpaDhGV0h0S21SbDhvSmRnbVJWaUdGZnRlcGxlUkFPZGdqWkkzVzFfZVZLSU9MSTlmM00xZFZqd2JkS0VmWDM1TzJ3ZldVMjhUWnp3TW0yYzNjRFFQRjBBT0pIYU9aRnFZcU5MT3I1WWcyYkRXbjNYb0o2OWdmMENONDhtTWdkTGJPY0lOR0c2M2t1T1pveW9vc0Rpc1BHYlZ0VDNqU29SLTh1bkdhLXNuenJyXzEyM0hqeWdvNVBncjNsdw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sumitomo Pharma (TSE:4506) Using Too Much Debt?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPMmQzZ1BmS1lPMUNYdjNFTHNrOGZZVEh2Y0dOc3VuQ0U2S01xS3FjWWw2Ri1JUVVMbjhkbFkyRllHaXhoQktNeV91SExUbmNvaTVPcWRaN002UHIxMDFGbzhqeWtxNDM2WFQyQk51dXJhNDMyNXo0cTBHUXBGd21RN0pMTk5WWkg3ZktoYkRCdmZDWlcwVkwtSXJkTV9XS09xN3dxMVZZVHR4T1FtU3NqNVNZLXNCazMxOFB5ZUpsamNVemlNQ0dnX1RRb05LeXhiX3R6N0Vn0gHbAUFVX3lxTFBMRFJNYW91NGhBRE5QcEtrQXgxcnBIR3RJNHlkTlZDN1VaaDZLV3lNNkVteXZBV0JmdDJqNW9QWkllcWlCTzYtWldIYXBJT0dLemZYalBPVGpUeUxtQVFqNkxYb25BWUdJNHI4UFlWSTQ4MldHMml5RzJ6OFBGdnZjQTlXY1FHNXZjYWp0WWZPeF82ZmhBTHRDNF83bElEbmJwX2ZyR1ZHTUpYd3UyTWJ3RDV0MG5yNHk4LW9YQWpqRzBnR1NLV1ZLVFJGQnlXSmhudEtrcmRkdzVyTQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-02T08:00:00+00:00", "published_display": "02 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Pharma Forms New Entity for Asian Business Spinoff", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQWtORHo4SGRRSi1GemFVOUtHZG15ZWxOSXNRQVVOcHpDNkJaMzEycFVzcFZiWjZYU2N1S3dhdXRqV0ItRlA1eDFiQ29Rdy1tS1NhZFdkbnJxZ2FfX1VlUnM2SldGTEEtNDRDaENPcDlKVDIxdDJzYU4zU3ZoVUg3cDZLOHBvdkN6QUZPcEliemNnMHBfVGxndy1qdjJEMkJmZTFvRGtxLWJQN0hVcGIyNHNNbjZhZEZrQ3ppZ0R6YTVDN0pGcHhWbXY0ZUxsaUpHNldONnR0OGd3MGl6bzNBZGdB?oc=5", "source_name": "marketscreener.com", "published_at": "2025-05-29T07:00:00+00:00", "published_display": "29 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Establishment of a Pharmaceutical Strategic Platform\uff1a Succession of Sumitomo Pharma\u2019s Business in Asia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5JNGVTUGVTZVdJN2ZwRUMtUnlRSzBCT2hkaXdEbEM0THl1emNDWU80RmhHb0pHQzl3TEY3M0s5Mkc3X0JiUEJEajhOdGhYbi13N1g4eVdLSUsyM2x1cFFIbURHcy1rbjA?oc=5", "source_name": "marubeni.com", "published_at": "2025-04-01T07:00:00+00:00", "published_display": "01 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUW4ybXdmX2dtb0xSZ0tBeF8tZmhaMXlzZ081enduWm9lMFlzaC1pVlRLeExtaUtyVEhYNzdzbWVjVzhKTjJxczFUcXRXNE5FeWxWN1RtMWVOUTFZLUxjaC1jdDhvc2JXZk5OT0N0TkhoejhSQ09aZG8xMDFCZlF3eUgwXzV3NVRmVXQxNnFMM0lSTDg1djJjaHNSdTNBRl95NWl3d1dLc1hVMmllX1U0a1pkWGluYjJieU4zNkMzTnkzaWpQc1RHR1E4QTdwTndBS3ViTGpGTmpGQmh2TUE?oc=5", "source_name": "PR Newswire", "published_at": "2022-10-23T07:00:00+00:00", "published_display": "23 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Offers to Buy All of Myovant in Deal Worth $2.5 Billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPTjNzaGNrVnEzZUI4SUQxUmk5bEtseWdqWk9rNkFQZmU1Q0F1MER5bE9XMmdXUGEzdUkzcHlELXJEMTkzWUVZUHVqNnNVc1BKUmdPTzNzcF9VNW1hRFV1OTJMbmxTV0FxT0dHUVJiRW9hYm5neVQ4djU3dUx4ZURxbGVtM19qQjZXRVZpeVBHOFVUTVYwcVh6aE9LWXZYMkI2RExRb0RHMzVLcHRmLVhacWk5c3A?oc=5", "source_name": "Bloomberg.com", "published_at": "2022-10-03T07:00:00+00:00", "published_display": "03 Oct 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitovant Biopharma and Sumitomo Pharma Announce Offer to Acquire Outstanding Shares of Myovant Sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxNWEt4SnNOMnNWamsxWkNfOWNaRTJocFpSaTdBWGI5SzR6UzBiNW9NMkN6Vi1HczBOTDM5WkV6enZvTkk2LW1HaHItaVpJVG5reEpvS3d1YjFFa08yRXRsQlU3QUsyc0c3QUlBbURoYWpnWTQ0QjJ2UThRX0Z6TWRoNkVCeUh3QUdxQjhOZ1k1bmxEMWswNTZwUkJ3c1hWYWxMNjFiMnJnbzVoX05rQjdPblVrQjEya1VQQ0hQMzJxbXVncDFnMlphdXNWa2Z5cUpHS3pyaWZ6dVJHcC1PVGhxR25hRjB0QXloTFkxTDA5MDlwMUE?oc=5", "source_name": "PR Newswire", "published_at": "2022-10-02T07:00:00+00:00", "published_display": "02 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 8, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 6, "score": 56, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 3.1, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1400.0, "latest_week": "2026-07-10", "one_week_move": -10.1, "four_week_move": 1.9, "twelve_week_move": -36.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.217324, "market_dynamics_buy_signal": false, "relative_strength": -43.834362, "fair_value_gap": 39.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 57.5205, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.1% over one week, +1.9% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Bloomberg.com", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "Investing.com", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "marubeni.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Earnings", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.1% over one week, +1.9% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Sumitomo Pharma Shares Drop After Stem-Therapy Backing"}], "updated_at": "2026-07-17T08:08:36.454537+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}